Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The goal of this clinical research study is to learn if RecoverMI care can help to shorten the time that patients are in the hospital after surgery and if it can help them recover sooner. RecoverMI includes the following parts: - Preoperative Education - Early oral intake - Early mobilization - Telemedicine


Study summary:

Study Groups: If you are found to be eligible to take part in this study, you will be randomly assigned (as in the flip of a coin) to 1 of 2 study groups. This is done because no one knows if one group is the same, better, or worse than the other group. - If you are assigned to Group 1, you will receive standard enhanced care after your surgery. - If you are assigned to Group 2, you will receive routine care after surgery, but you will also receive accelerated recovery, early discharge, and Telemedicine. Participants will be loaned an iPad to use for video-conferencing and text messaging in this study. This is an investigational study. The study doctor can explain how RecoverMI is designed to work. Up to 32 participants will be enrolled in this study. All will take part at MD Anderson.


Criteria:

Inclusion Criteria: 1. Patient has histologically proven colorectal cancer or polyp(s) that is planned to be treated by surgical resection performed with curative intent. 2. Patient is >/= 18 years and younger than 80 years. 3. Elective minimally invasive operation. 4. No planned ostomy creation at time of enrollment. 5. Serum creatinine <1.5 measured within 30 days of surgery. 6. Ability to speak, read, and understand English. Exclusion Criteria: 1. Strong, self-reported history of postoperative nausea and vomiting. 2. History of congestive heart failure. Systolic heart failure defined as Ejection Fraction (EF) </= 40%), or diastolic heart failure defined as EF >40% PLUS systemic manifestation of heart failure.


NCT ID:

NCT02613728


Primary Contact:

Principal Investigator
George Chang, MD, MS
M.D. Anderson Cancer Center


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.